Published: May 15th 2024 | Updated: May 20th 2024
Minimizing the carbon footprint of ophthalmic surgeries
Published: November 20th 2024 | Updated: December 1st 2024
Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300
Published: November 19th 2024 | Updated: December 1st 2024
SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension
Published: November 1st 2024 | Updated: December 1st 2024
AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis
Published: November 14th 2024 | Updated: December 1st 2024
Sun Pharma announces positive Phase 4 data results in dry eye disease
Published: November 17th 2024 | Updated: December 1st 2024
This Week in Ophthalmology: Week of November 11, 2024